Article | October 30, 2020

Rare Disease Studies: A Comfortable Patient Is A Retained Patient

Source: ISR Reports

By Sherry Hubbard-Bednasz

Young Chinese man in mask sitting in lab.jpg

What is comfort anyway? Being home. Your own bed. Your mom’s homemade anything. In rare disease studies, those things are suspended. Get through the trial and then you can seek comfort. But does it have to be this way?

One could say the cards are stacked against rare disease studies. We often talk about the challenges of clinical trials in the frame of typical studies – drug development efforts intended to improve the condition of many. The key word is many. Rare diseases do not have numbers on their side. This is not to say typical studies are cake walks. There are no guarantees with human trials. And definitely not in the midst of a global pandemic.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: